|
|
Post by sportsrancho on May 13, 2021 12:35:27 GMT -5
Did we ever figure out last time if he even uses afrezza? Yes, and I believe he will be giving more of his personal story soon. |
|
|
|
Post by sportsrancho on May 13, 2021 12:39:13 GMT -5
I think I remember that they will not let you put the name of the product on the car. They being the FDA. I think nylefty knows.
|
|
|
|
Post by mnkdfann on May 13, 2021 12:48:31 GMT -5
Google search "tired of pricks". First in line. Well, that first in line hit is a very brief mention at motorsport.com. None of the other first page hits even mention Mannkind. I doubt the motorsport.com hit has much longevity as a first in liner and if it does, it isn't really helping. The 'article' at motorsport.com barely mentions diabetes, and doesn't mention Afrezza at all. In fact, anyone reading that article could come away with the impression that Mannkind is a lifestyle / diabetes coaching practice ("Conor exemplifies the very spirit of MannKind’s mission – living life without limits"). |
|
|
|
Post by nylefty on May 13, 2021 12:50:28 GMT -5
MNKD has a strange approach to marketing. Many here bemoan the fact that are still too many health professionals who have not heard of Afrezza. How does this racing sponsorship help. I do not see the word Afrezza anywhere on the car. Is the purpose to sell Afrezza or spotlight Mannkind for investors and shareholders and have something for Castagna to talk about?
If you are selling a product, name recognition of the product is more important than having the company name on the car in several places. How many times do we have to explain that under FDA rules MannKind can't use the word Afrezza in any kind of advertising without including all the black box warnings? There's no way to refer to Afrezza by name on a billboard, a race car, or any other place where all the warnings can't be legibly included. However, the FDA does allow URLs that take you to a product page that does include the warnings. |
|
|
|
Post by oldfishtowner on May 13, 2021 13:15:06 GMT -5
MNKD has a strange approach to marketing. Many here bemoan the fact that are still too many health professionals who have not heard of Afrezza. How does this racing sponsorship help. I do not see the word Afrezza anywhere on the car. Is the purpose to sell Afrezza or spotlight Mannkind for investors and shareholders and have something for Castagna to talk about?
If you are selling a product, name recognition of the product is more important than having the company name on the car in several places. In the PR, Afrezza isn't mentioned in the main text at all; it is only mentioned in the section "About Mannkind Corporation." If you are selling a product, the product has to be front and center, otherwise, what is the point?
Afrezza isn't mentioned in Conor's tweet either. This marketing effort may be cutesy, but I have difficulty seeing how it will be effective. One has to ask if the slogan on the side of the car refers to Afrezza or the CEO.
How many times do we have to explain thar under FDA rules MannKind can't use the word Afrezza in any kind of advertising without including all the black box warnings? There's no way to refer to Afrezza by name on a billboard, a race car, or any other place where all the warnings can't be legibly included. However, the FDA does allow URLs that take you to a product page that does include the warnings. Thanks for the reminder. But that doesn't change the fact that name recognition is important while you have the attention of those watching. Mannkind is not a product like Firestone, Hertz, Pennzoil, etc. Afrezza is the product. MNKD is requiring people to take that extra step an go to the URL to find out what the product is. IMO they will immediately lose half or more of the intended audience who won't do that and will never know what the product is. I would love to be proven wrong and have scripts accelerate as fast as Conor's car, but I don't think that this marketing effort will be any more successful than ones in the past. |
|
|
|
Post by sportsrancho on May 13, 2021 13:21:47 GMT -5
He needs to win and talk about Afrezza. Otherwise not worth the money.
|
|
|
|
Post by od on May 13, 2021 13:24:15 GMT -5
Google search "tired of pricks". First in line. Great, except 'Afrezza' is the brand, and considering the lack of Afrezza brand awareness (including health care professionals), is 'Tired of pricks' what the broad consumer community should be remembering? I hope MannKind and the agency tested the heck out of 'Tired of pricks'. I also hope 'Tired of pricks' is part of the health care professional campaign, so that they know what consumers are talking about. I know some of this is walking and chewing gum at the same time, but... |
|
|
|
Post by nylefty on May 13, 2021 13:40:56 GMT -5
How many times do we have to explain thar under FDA rules MannKind can't use the word Afrezza in any kind of advertising without including all the black box warnings? There's no way to refer to Afrezza by name on a billboard, a race car, or any other place where all the warnings can't be legibly included. However, the FDA does allow URLs that take you to a product page that does include the warnings. Thanks for the reminder. But that doesn't change the fact that name recognition is important while you have the attention of those watching. Mannkind is not a product like Firestone, Hertz, Pennzoil, etc. Afrezza is the product. MNKD is requiring people to take that extra step an go to the URL to find out what the product is. IMO they will immediately lose half or more of the intended audience who won't do that and will never know what the product is. I would love to be proven wrong and have scripts accelerate as fast as Conor's car, but I don't think that this marketing effort will be any more successful than ones in the past. No. MannKind isn't requiring people to take that extra step; the FDA is. What would be your solution to this problem? |
|
|
|
Post by od on May 13, 2021 13:53:48 GMT -5
Thanks for the reminder. But that doesn't change the fact that name recognition is important while you have the attention of those watching. Mannkind is not a product like Firestone, Hertz, Pennzoil, etc. Afrezza is the product. MNKD is requiring people to take that extra step an go to the URL to find out what the product is. IMO they will immediately lose half or more of the intended audience who won't do that and will never know what the product is. I would love to be proven wrong and have scripts accelerate as fast as Conor's car, but I don't think that this marketing effort will be any more successful than ones in the past. No. MannKind isn't requiring people to take that extra step; the FDA is. What would be your solution to this problem? NYL - do you think this campaign and slogan is a solution? If the original Conor campaign moved the needle (can't tell from the Rx count), perhaps this is a solution (but I am skeptical). |
|
|
|
Post by mytakeonit on May 13, 2021 14:00:57 GMT -5
Hmmm ... will people buy a "Tired of Pricks" t-shirt  I better call my t-shirt making friend !!! But, that's mytakeonit |
|
|
|
Post by shawnonafrezza on May 13, 2021 14:07:45 GMT -5
This will fail (I do own stock so am I allowed to vent but with the perspective as a t1).
Dexcom sponsors people/casts. Insulet sponsors people/podcasts. Companion Medical ran an aggressive IG campaign for the InPen. Tandem on the X2. Everyone in the devices world (none of the insulin manufactures need to advertise for obvious reasons).
What's the difference? They sponsor people who have the disease, talk about the disease, and entire social media campaigns/lives show it in many of their posts. So you get a car that drives around and hope a PWD sees it or do you go to where the PWD is? It's blatantly obvious which one works. 1/100 people have T1, 1/10 have T2, at best 10% of people see your ad and care vs near 100%.
|
|
|
|
Post by hellodolly on May 13, 2021 14:19:16 GMT -5
Conor seems like a good guy, but he sure as hell ain’t a celebrity. He’s a mediocre Indy car driver whose best finish is 17th. • Has wins in both Star Mazda (now Indy Pro 2000) and Indy Lights competition and won the 2010 Indy Pro 2000 title • Has tested an F1 car for Force India. Won at Barcelona in GP3 and was the inaugural MRF Challenge Series champion in India. • A second-generation race driver, Conor is the son of Derek Daly, who reached the pinnacle of the sport, competing in Formula 1 and Indy cars for well over a decade. His mother, Beth Boles, won a Novice Jet Ski World title in 1990 and his stepfather J. Douglas Boles is the president of Indianapolis Motor Speedway. Great stuff. That entire car is MNKD deco and not a tiny little 4X4 sticker. The slogan "Tired of pricks?" will surely get people's attention, asking more questions, most certainly anyone using needles will want to look deeper into the catchy slogan. The people in the race car industry are very familiar with the pedigree of Conor. Fans of Indy are insanely passionate about the cars, the race, the drivers, etc. I love this!! Great call Mike! I hope this car is used for the entire circuit. |
|
|
|
Post by cretin11 on May 13, 2021 14:26:05 GMT -5
Conor also has 80k Twitter followers. Not bad for a 17th place guy, eh? Mango I can’t tell if you’re being facetious but that’s not your typical style so guessing you’re serious. 80K followers is not a large number in the world of Twitter, it’s a modest number for a sports star (“star” maybe too generous a word for someone with such a small following). This is an odd use of funds for a company of our size and marketing budget. The last time around didn’t move the needle (pun intended) as far as we know. This is a gamble with our money, it could possibly pay off if and only if Conor WINS the Indy 500. Any lower finish and there’s simply not the bang for the buck we would need to make a sponsorship like this financially worthwhile. |
|
|
|
Post by hellodolly on May 13, 2021 14:29:54 GMT -5
MannKind will also be a primary sponsor for Ed Carpenter Racing as Daly debuts the No. 20 MannKind Chevrolet at the May 15th running of the GMR Grand Prix at Indianapolis Motor Speedway.
When ECR team owner Ed Carpenter steps back into the No. 20 for the Indianapolis 500 later this month, Daly will shift over to the No. 47 U.S. Air Force Chevrolet.
|
|
|
|
Post by cretin11 on May 13, 2021 14:39:53 GMT -5
All the money used on this odd race car sponsorship (this is the marketing plan developed over the past year?!) could be better used by collaborating with VDEX to get as many patients into the VDEX protocol.
Having people learn about Afrezza from a race car sticker will result in them asking their doctors about Afrezza, if we are lucky to even have that happen on a large scale. Then they will get told by the doctor that Afrezza is not safe, or confusing, or there’s no coverage, etc. Or maybe they’ll actually get the prescription - and then the dosing won’t be properly taught, resulting in sub optimal results and us losing a potential lifetime patient.
OR... we spend our energy not on MC getting great seats to an Indy car race, but instead on working with VDEX so those patients learn how to properly use Afrezza. Result? Afrezza patients for life!
|
|
I better call my t-shirt making friend !!!
